Nebivolol regulatory update

FDA accepted for filing an NDA from MYL subsidiary Bertek Pharmaceuticals Inc. (Research Triangle Park, N.C.) for nebivolol to treat hypertension. The NDA has a PDUFA date of Feb. 28, 2005. MYL licens...